insights_auto
Why is PTGX up 3,05%?
Dive Deeperchevron_right
PTGX:NASDAQ
Protagonist Therapeutics Inc
144,18 US$
arrow_upward
+3,05%(+4,27) 1D
9 ოქტ, 15:42:06 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTGX...
Open
139,91 US$
High
146,30 US$
Low
138,95 US$
Mkt. cap
9,33 მლრდ.
Avg. vol.
714,90 ათ.
Volume
497,30 ათ.
P/E ratio
139,02
52-wk high
160,81 US$
52-wk low
65,77 US$
EPS
1,04 US$
Beta
1,53
Shares outstanding
64,71 მლნ.
No. of employees
141
Open
139,91 US$
High
146,30 US$
Low
138,95 US$
Mkt. cap
9,33 მლრდ.
Avg. vol.
714,90 ათ.
Volume
497,30 ათ.
P/E ratio
139,02
52-wk high
160,81 US$
52-wk low
65,77 US$
EPS
1,04 US$
Beta
1,53
Shares outstanding
64,71 მლნ.
No. of employees
141
News stories
From web sources and news partners
https://www.dars.gov.et/
·
2 თვის წინ
PTGX Q1 2026 Earnings: Unexpected Profit Delivers 109.2% EPS Surprise as Shares Slip - Earnings Momentum Score
About Protagonist Therapeutics Inc
CEO-
Employees141
Founded2006
HeadquartersNewark, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Websiteprotagonist-inc.com